Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

233 results about "Panic" patented technology

Panic is a sudden sensation of fear, which is so strong as to dominate or prevent reason and logical thinking, replacing it with overwhelming feelings of anxiety and frantic agitation consistent with an animalistic fight-or-flight reaction. Panic may occur singularly in individuals or manifest suddenly in large groups as mass panic (closely related to herd behavior).

Recording and reporting device, method, and application

A method and/or a computer readable medium and a computer-executable set of instructions on the computer readable medium, and/or a product or processing system such as a handheld communication device or computer, for carrying out the method, the method allowing a user to initiate capturing images during an experience such as a driving experience and submitting an electronic communication containing at least captured images for a threshold duration before and/or after detecting a threshold magnitude motion, such as one emulating a car accident. The electronic communication can be configured to be sent to a predestinated destination such as an insurance agent, emergency respondent, family member, employer, or any other destination, and may include additional information such as accident location, user information, and vehicle information. The processing system display may provide the user the option to, or the processing system may automatically, call a desired destination such as an emergency respondent. The processing system may respond to computer-executable instructions to delete from a threshold history of the captured image as the image capture device thereof records images to preserve memory space, keeping the most recent threshold duration. The processing system may respond to computer-executable instructions to continue recording after the threshold magnitude motion is detected for a threshold duration prior to submitting the captured image. The display of the processing system may include a user-selectable panic object to allow manual submission of a threshold duration of the image captured without the processing system having detected the threshold magnitude motion.
Owner:RASHIDI HABIB

Adaptive topology discovery in communication networks

A topology discovery process is used to discover all of the links in an ad hoc network and thereby ascertain the topology of the entire network. One of the nodes of the network, referred to as the coordinator, receives the topology information which can then be used to, for example, distribute a routing table to each other node of the network. The process has a Diffusion phase in which a k-resilient mesh, k>1, is created by propagating a topology request message through the network. Through this process, the nodes obtain information from which they are able to discern their local neighbor information. In a subsequent, Gathering phase, the local neighbor information is reported upstream from a node to its parents in the mesh and thence to the parents' parents and so forth back to the coordinator. The robustness of the Diffusion phase is enhanced by allowing a node to have more than one parent as well as by a number of techniques, including use of a so-called diffusion acknowledgement message. The robustness of the Gathering phase is enhanced by a number of techniques including the use of timeouts that ensure that a node will report its neighbor information upstream even if it never receives neighbor information from one or more downstream neighbors and the use of a panic mode that enhances the probability that a node will get its neighbor information, and its descendents' neighbor information, reported upstream even if that node has lost connectivity with all of its parents.
Owner:AMERICAN TELEPHONE & TELEGRAPH CO

Modified release compositions of milnacipran

A once-a-day oral milnacipran modified release formulation has been developed. The formulation comprises an extended release dosage unit (optionally containing the immediate release portion) coated with delayed release coating. The milnacipran composition, when administered orally, first passes through the stomach releasing from zero to less than 10% of the total milnacipran dose and then enters the intestines where drug is released slowly over an extended period of time. The release profile is characterized by a 0.05-4 hours lag time period during which less than 10% of the total milnacipran dose is released followed by a slow or extended release of the remaining drug over a defined period of time. The composition provides in vivo drug plasma levels characterized by Tmax at 4-10 hours and an approximately linear drop-off thereafter and Cmax below 3000 ng / ml, preferably below 2000 ng / ml, and most preferably below 1000 ng / ml. The composition allows milnacipran to be delivered over approximately 24 hours, when administered to a patient in need, resulting in diminished incidence or decreased intensity of common milnacipran side effects such as sleep disturbance, nausea, vomiting, headache, tremulousness, anxiety, panic attacks, palpitations, urinary retention, orthostatic hypotension, diaphoresis, chest pain, rash, weight gain, back pain, constipation, vertigo, increased sweating, agitation, hot flushes, tremors, fatigue, somnolence, dyspepsia, dysoria, nervousness, dry mouth, abdominal pain, irritability, and insomnia.
Owner:COLLEGIUM PHARMA INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products